Gene · 84939
Papers3,940
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,940
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clear cell renal cell carcinoma combined with intravascular large B-cell lymphoma: a case report and review of the literature. | Front Oncol | 2026 | 41788981 | PubTator, text mining | PubMed |
| Acute liver failure and severe lactic acidosis as initial manifestations of primary intestinal diffuse large B-cell lymphoma: Case report. | Leuk Res Rep | 2026 | 41783658 | PubTator, text mining | PubMed |
| Case Report: Glofitamab in the treatment of a patient with central nervous system-involved Burkitt lymphoma. | Front Oncol | 2026 | 41783442 | PubTator, text mining | PubMed |
| Utilization and Outcomes of High-Dose Methotrexate in CNS Lymphoma Patients on Hemodialysis: A Report of 2 Cases. | Case Rep Oncol | 2026 | 41782706 | PubTator, text mining | PubMed |
| CD5-Positive Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type: An Unusual Presentation. | Am J Dermatopathol | 2026 | 41779629 | PubTator, text mining | PubMed |
| Primary Breast Lymphoma in Mexico: A 15-Year Retrospective Case Series From a Tertiary Center Suggesting a Distinctly Early Age at Presentation. | Cureus | 2026 | 41777270 | PubTator, text mining | PubMed |
| Acute Superior Vena Cava Obstruction Mimicking Aortic Dissection: A Case of Primary Mediastinal Large B-cell Lymphoma. | Cureus | 2026 | 41769511 | PubTator, text mining | PubMed |
| Born with two faces: sequential DLBCL, NOS and TFHL-AI with TET2 mutation - a case report. | Front Immunol | 2026 | 41766912 | PubTator, text mining | PubMed |
| Targeting cellular source-specific CXCL9 signaling for immunotherapy in oral squamous cell carcinoma. | Front Immunol | 2026 | 41766875 | PubTator, text mining | PubMed |
| Temporal association of diffuse large B-cell lymphoma with PD-1 inhibitor therapy in a patient with gastric adenocarcinoma: a case report. | Front Immunol | 2026 | 41766867 | PubTator, text mining | PubMed |
| Low hemoglobin as a novel prognostic biomarker in EBV-positive diffuse large B-cell lymphoma patients: a clinical feature analysis of 99 cases from Zhejiang, Southeast China. | Ann Hematol | 2026 | 41762240 | PubTator, text mining | PubMed |
| Association between CD56, CD38 and chronic endometritis and analysis of pregnancy prognosis: a single-center retrospective cohort study. | Front Med (Lausanne) | 2026 | 41756395 | PubTator, text mining | PubMed |
Small B-cell lymphoma highly suspicious for splenic marginal zone lymphoma with MYD88 L265P mutation and MYC copy-number gain presenting as severe autoimmune hemolytic anemia: a case report with literature review. | Front Immunol | 2026 | 41756269 | PubTator, text mining | PubMed |
| Primary Dural Diffuse Large B-Cell Lymphoma: A Report of a Rare Case and Review of the Literature. | Cureus | 2026 | 41755948 | PubTator, text mining | PubMed |
| Large B-cell Lymphoma With IRF4 Rearrangement in the Elderly. | Cureus | 2026 | 41755940 | PubTator, text mining | PubMed |
| Primary Adrenal Gland Lymphoma: Report of 13 Cases-A Retrospective Multicenter Polish Lymphoma Research Group Analysis. | Life (Basel) | 2026 | 41752871 | PubTator, text mining | PubMed |
| Burkitt Lymphoma-A Guide to Biological Features, Diagnosis and Differential Diagnosis. | Cancers (Basel) | 2026 | 41749833 | PubTator, text mining | PubMed |
| A rare case report of relapsed/refractory primary cutaneous diffuse large B-cell lymphoma, leg type, treated with Epcoritamab: results obtained and lesson learned. | Front Oncol | 2026 | 41743953 | PubTator, text mining | PubMed |
| Case Report: A rare case of Epstein-Barr virus mucocutaneous ulcers occurring in the eyeball and literature review. | Front Med (Lausanne) | 2026 | 41743091 | PubTator, text mining | PubMed |
| Early Neurotoxicity following a Single Dose of Brentuximab in a Patient with Epstein Bar Virus Driven Lymphoma: A Case Report. | Case Rep Oncol | 2026 | 41737132 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84939/papers?page=4